|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D16.4 |
Benign neoplasm of bones of skull and face
|
D164 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 48.29%
|
19.36%
|
12.19%
|
7.36%
|
3.82%
|
2.09%
|
1.41%
|
1.29%
|
0.89%
|
0.60%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D16.4*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
70486
|
CT MAXILLOFACIAL W/O DYE |
258
|
258
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
236
|
237
|
|
J2405
|
ONDANSETRON HCL INJECTION |
199
|
906
|
|
88311
|
DECALCIFY TISSUE |
195
|
215
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
191
|
6,033
|
|
J3010
|
FENTANYL CITRATE INJECTION |
189
|
362
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
179
|
1,415
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
168
|
216
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
150
|
150
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
125
|
516
|
|
C1889
|
IMPLANT/INSERT DEVICE, NOC |
108
|
157
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
105
|
208
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
101
|
1,312
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
92
|
197
|
|
G1004
|
CDSM NDSC |
91
|
94
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
86
|
151
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
76
|
76
|
|
J2001
|
LIDOCAINE INJECTION |
76
|
634
|
|
J7120
|
RINGERS LACTATE INFUSION |
74
|
101
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
64
|
5,506
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D16.4 related to the following DRG Codes:
011-013
564-566
|
